Ann: IHL-42X patent update & open label extension study approval, page-104

Yes.
That will be a huge development.
The company will not only start developing a revenue stream from those sales, but it will receive potentially valuable data.
I do not know this for a fact, but I imagine that data might prove useful in the package submitted to the FDA for IHL42x's NDA.

There are some folks in this forum who have OSA: would any of you seek through your doctor to have access to IHL42x under the SAS? If so, it would be amazing to get your feedback when that time comes.